{"id":9778,"date":"2025-05-16T22:21:31","date_gmt":"2025-05-16T19:21:31","guid":{"rendered":"https:\/\/medilab.km.ua\/?p=9778"},"modified":"2026-07-23T11:34:48","modified_gmt":"2026-07-23T08:34:48","slug":"analiz-krovi-na-sa-72-4-marker-dlya-monitoryngu-onkologichnyh-zahvoryuvan","status":"publish","type":"post","link":"https:\/\/medilab.km.ua\/en\/analiz-krovi-na-sa-72-4-marker-dlya-monitoryngu-onkologichnyh-zahvoryuvan\/","title":{"rendered":"Blood test for CA-72-4: a marker for monitoring cancer diseases"},"content":{"rendered":"<h2 data-start=\"247\" data-end=\"293\"><strong data-start=\"250\" data-end=\"293\">General characteristics of the marker CA-72-4<\/strong><\/h2>\n<p data-start=\"295\" data-end=\"638\">CA-72-4 (Cancer Antigen 72-4) is a tumor-associated glycoprotein, specifically tumor-associated glycoprotein 72 (TAG-72), which belongs to the mucin-like proteins. Normally, it practically does not circulate in the blood, but its expression increases significantly in a number of malignant processes, especially in the case of adenocarcinomas of the gastrointestinal tract and ovaries.<\/p>\n<h2 data-start=\"640\" data-end=\"682\"><strong data-start=\"643\" data-end=\"682\">Who and when is this test prescribed?<\/strong><\/h2>\n<p data-start=\"684\" data-end=\"725\">The CA-72-4 test is usually prescribed for:<\/p>\n<ul data-start=\"727\" data-end=\"1088\">\n<li data-start=\"727\" data-end=\"793\">\n<p data-start=\"729\" data-end=\"793\">Patients with suspected <strong data-start=\"753\" data-end=\"792\">stomach, colon, ovarian cancer<\/strong>.<\/p>\n<\/li>\n<li data-start=\"794\" data-end=\"899\">\n<p data-start=\"796\" data-end=\"899\">After the diagnosis is made - for <strong data-start=\"830\" data-end=\"898\">monitoring the effectiveness of chemotherapy or surgical treatment<\/strong>.<\/p>\n<\/li>\n<li data-start=\"900\" data-end=\"990\">\n<p data-start=\"902\" data-end=\"990\">For <strong data-start=\"906\" data-end=\"940\">timely detection of relapse<\/strong> in patients with already diagnosed oncological pathology.<\/p>\n<\/li>\n<li data-start=\"991\" data-end=\"1088\">\n<p data-start=\"993\" data-end=\"1088\">Less often - as <strong data-start=\"1004\" data-end=\"1038\">part of an extended examination<\/strong> with nonspecific gastroenterological symptoms.<\/p>\n<\/li>\n<\/ul>\n<h2 data-start=\"1078\" data-end=\"1106\"><strong data-start=\"1081\" data-end=\"1106\">Preparation for analysis<\/strong><\/h2>\n<ul data-start=\"1108\" data-end=\"1424\">\n<li data-start=\"1108\" data-end=\"1171\">\n<p data-start=\"1110\" data-end=\"1171\"><strong data-start=\"1110\" data-end=\"1124\">Pick-up time<\/strong>: The analysis is performed on an empty stomach, preferably in the morning.<\/p>\n<\/li>\n<li data-start=\"1172\" data-end=\"1305\">\n<p data-start=\"1174\" data-end=\"1305\"><strong data-start=\"1174\" data-end=\"1185\">Avoid<\/strong>: It is recommended to refrain from alcohol, fatty foods, and intense physical activity 24 hours before the test.<\/p>\n<\/li>\n<li data-start=\"1306\" data-end=\"1424\">\n<p data-start=\"1308\" data-end=\"1424\"><strong data-start=\"1308\" data-end=\"1323\">Medications<\/strong>: Tell your doctor about all medications you are taking, as some of them may affect the test results.<\/p>\n<\/li>\n<\/ul>\n<h2 data-start=\"1426\" data-end=\"1480\"><strong data-start=\"1429\" data-end=\"1480\">Normal values and interpretation of results<\/strong><\/h2>\n<div class=\"_tableContainer_16hzy_1\">\n<div class=\"_tableWrapper_16hzy_14 group flex w-fit flex-col-reverse\">\n<div class=\"table-scroll\"><table class=\"w-fit min-w-(--thread-content-width)\" data-start=\"1482\" data-end=\"1691\">\n<thead data-start=\"1482\" data-end=\"1524\">\n<tr data-start=\"1482\" data-end=\"1524\">\n<th data-start=\"1482\" data-end=\"1507\" data-col-size=\"sm\">CA-72-4 level (IU\/ml)<\/th>\n<th data-start=\"1507\" data-end=\"1524\" data-col-size=\"md\">Interpretation<\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"1568\" data-end=\"1691\">\n<tr data-start=\"1568\" data-end=\"1610\">\n<td data-start=\"1568\" data-end=\"1593\" data-col-size=\"sm\">0 \u2013 6.9<\/td>\n<td data-start=\"1593\" data-end=\"1610\" data-col-size=\"md\">Norm<\/td>\n<\/tr>\n<tr data-start=\"1611\" data-end=\"1691\">\n<td data-start=\"1611\" data-end=\"1636\" data-col-size=\"sm\">&gt; 6.9<\/td>\n<td data-start=\"1636\" data-end=\"1691\" data-col-size=\"md\">Possible increase, requires additional examination<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<div class=\"sticky end-(--thread-content-margin) h-0 self-end select-none\">\n<div class=\"absolute end-0 flex items-end\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<p data-start=\"1693\" data-end=\"1923\"><strong data-start=\"1693\" data-end=\"1705\">Note<\/strong>: Elevated levels of CA-72-4 do not always indicate the presence of a malignant process. It can be elevated in some benign conditions, such as inflammatory diseases of the gastrointestinal tract, liver, or ovaries.<\/p>\n<h2 data-start=\"1925\" data-end=\"1961\"><strong data-start=\"1928\" data-end=\"1961\">Advantages and limitations of the analysis<\/strong><\/h2>\n<ul data-start=\"1963\" data-end=\"2271\">\n<li data-start=\"1963\" data-end=\"2129\">\n<p data-start=\"1965\" data-end=\"1978\"><strong data-start=\"1965\" data-end=\"1977\">Advantages<\/strong>:<\/p>\n<ul data-start=\"1981\" data-end=\"2129\">\n<li data-start=\"1981\" data-end=\"2055\">\n<p data-start=\"1983\" data-end=\"2055\">High specificity for some types of cancer, especially stomach and ovarian.<\/p>\n<\/li>\n<li data-start=\"2058\" data-end=\"2129\">\n<p data-start=\"2060\" data-end=\"2129\">Ability to monitor treatment effectiveness and detect relapses.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li data-start=\"2130\" data-end=\"2271\">\n<p data-start=\"2132\" data-end=\"2146\"><strong data-start=\"2132\" data-end=\"2145\">Limitation<\/strong>:<\/p>\n<ul data-start=\"2149\" data-end=\"2271\">\n<li data-start=\"2149\" data-end=\"2201\">\n<p data-start=\"2151\" data-end=\"2201\">Low sensitivity in early stages of the disease.<\/p>\n<\/li>\n<li data-start=\"2204\" data-end=\"2271\">\n<p data-start=\"2206\" data-end=\"2271\">False-positive results are possible for some benign conditions.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-9780\" src=\"https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/05\/333-2.jpg\" alt=\"Visualization of elevated CA-72-4 levels on a chart\" width=\"1200\" height=\"750\" srcset=\"https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/05\/333-2.jpg 1200w, https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/05\/333-2-150x94.jpg 150w, https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/05\/333-2-600x375.jpg 600w, https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/05\/333-2-300x188.jpg 300w, https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/05\/333-2-1024x640.jpg 1024w, https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/05\/333-2-768x480.jpg 768w\" sizes=\"(max-width: 1200px) 100vw, 1200px\" \/><\/p>\n<h2 data-start=\"2273\" data-end=\"2313\"><strong data-start=\"2276\" data-end=\"2313\">Combination with other tumor markers<\/strong><\/h2>\n<p data-start=\"2315\" data-end=\"2410\">To increase diagnostic accuracy, the CA-72-4 test is often combined with other tumor markers:<\/p>\n<ul data-start=\"2412\" data-end=\"2660\">\n<li data-start=\"2412\" data-end=\"2493\">\n<p data-start=\"2414\" data-end=\"2493\"><strong data-start=\"2414\" data-end=\"2431\">CA-72-4 + CEA<\/strong>: For the diagnosis and monitoring of stomach and colon cancer.<\/p>\n<\/li>\n<li data-start=\"2494\" data-end=\"2567\">\n<p data-start=\"2496\" data-end=\"2567\"><strong data-start=\"2496\" data-end=\"2516\">CA-72-4 + <a href=\"https:\/\/medilab.km.ua\/en\/how-to-understand-the-meaning-of-the-word-quot-sa-125-quot-and-why-it-is-important-for-women\/\">CA-125<\/a><\/strong>: For the detection and monitoring of ovarian cancer.<\/p>\n<\/li>\n<li data-start=\"2568\" data-end=\"2660\">\n<p data-start=\"2570\" data-end=\"2660\"><strong data-start=\"2570\" data-end=\"2591\">CA-72-4 + <a href=\"https:\/\/medilab.km.ua\/en\/oncomarker-sa-19-9-not-only-for-esophageal-cancer-but-what-does-this-analysis-really-show\/\">CA-19-9<\/a><\/strong>: For the diagnosis of pancreatic and biliary tract tumors.<\/p>\n<\/li>\n<\/ul>\n<h2 data-start=\"3035\" data-end=\"3068\"><strong data-start=\"3038\" data-end=\"3068\">Recommendations for patients<\/strong><\/h2>\n<ul data-start=\"3070\" data-end=\"3369\">\n<li data-start=\"3070\" data-end=\"3162\">\n<p data-start=\"3072\" data-end=\"3162\">Don&#039;t panic if the reading is above normal. This is just an indicator that needs confirmation.<\/p>\n<\/li>\n<li data-start=\"3163\" data-end=\"3267\">\n<p data-start=\"3165\" data-end=\"3267\">Regularity: Patients with stomach cancer are recommended to undergo testing every 3\u20136 months after treatment.<\/p>\n<\/li>\n<li data-start=\"3268\" data-end=\"3369\">\n<p data-start=\"3270\" data-end=\"3369\">Discuss the results only with an oncologist or gastroenterologist, do not interpret them yourself.<\/p>\n<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>General characteristics of the CA-72-4 marker CA-72-4 (Cancer Antigen 72-4) is a tumor-associated glycoprotein, in particular tumor-associated glycoprotein 72 (TAG-72), which belongs to<\/p>","protected":false},"author":627,"featured_media":9779,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,233],"tags":[],"class_list":["post-9778","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-zahvoryuvannya-ta-symptomy","category-rozshyfrovka-analiziv-ta-pidgotovka"],"_links":{"self":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts\/9778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/users\/627"}],"replies":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/comments?post=9778"}],"version-history":[{"count":0,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts\/9778\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/media\/9779"}],"wp:attachment":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/media?parent=9778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/categories?post=9778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/tags?post=9778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}